BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 29260040)

  • 1. Cognitive impairment in neuromyelitis optica spectrum disorders: A comparison of the Wechsler Adult Intelligence Scale-III and the Wechsler Memory Scale Revised with the Rao Brief Repeatable Neuropsychological Battery.
    Fujimori J; Nakashima I; Baba T; Meguro Y; Ogawa R; Fujihara K
    eNeurologicalSci; 2017 Dec; 9():3-7. PubMed ID: 29260040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of cognitive and brain grey matter volume profiles between multiple sclerosis and neuromyelitis optica spectrum disorder.
    Masuda H; Hirano S; Takahashi N; Hatsugano E; Uzawa A; Uchida T; Ohtani R; Kuwabara S; Mori M
    PLoS One; 2017; 12(8):e0184012. PubMed ID: 28846745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of intelligence quotient in patients with neuromyelitis optica spectrum disease and multiple sclerosis.
    Ashtari F; Manouchehri N; Shaygannejad V; Barekatain M; Adibi I; Afshari-Safavi A; Ramezani N; Ghalamkari A; Barzegar M
    Mult Scler Relat Disord; 2023 Feb; 70():104492. PubMed ID: 36587484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Volume of hippocampal subfields and cognitive deficits in neuromyelitis optica spectrum disorders.
    Cacciaguerra L; Valsasina P; Meani A; Riccitelli GC; Radaelli M; Rocca MA; Filippi M
    Eur J Neurol; 2021 Dec; 28(12):4167-4177. PubMed ID: 34415660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive impairment and cortical degeneration in neuromyelitis optica.
    Saji E; Arakawa M; Yanagawa K; Toyoshima Y; Yokoseki A; Okamoto K; Otsuki M; Akazawa K; Kakita A; Takahashi H; Nishizawa M; Kawachi I
    Ann Neurol; 2013 Jan; 73(1):65-76. PubMed ID: 23378324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive impairment differs between neuromyelitis optica spectrum disorder and multiple sclerosis.
    Kim SH; Kwak K; Jeong IH; Hyun JW; Jo HJ; Joung A; Yu ES; Kim JH; Lee SH; Yun S; Joo J; Lee DK; Lee JM; Kim HJ
    Mult Scler; 2016 Dec; 22(14):1850-1858. PubMed ID: 26920380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Widespread cortical thinning in patients with neuromyelitis optica spectrum disorder.
    Kim SH; Kwak K; Hyun JW; Jeong IH; Jo HJ; Joung A; Kim JH; Lee SH; Yun S; Joo J; Lee JM; Kim HJ
    Eur J Neurol; 2016 Jul; 23(7):1165-73. PubMed ID: 27108769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive impairment in Neuromyelitis Optica Spectrum Disorder: A retrospective study using the Brief International cognitive Assessment for Multiple Sclerosis (BICAMS).
    Lopes C; Sousa C; Fraga A; Guimarães J; Vicente S; Sá MJ
    Appl Neuropsychol Adult; 2023 May; ():1-7. PubMed ID: 37195824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of cognitive impairment in patients with neuromyelitis optica spectrum disorder in Mexico.
    Valdivia-Tangarife ER; Cortés-Enríquez F; Morlett-Paredes A; Villaseñor-Cabrera T; Gámez-Nava JI; Mireles-Ramírez MA; González-López L; Macías-Islas MÁ
    Mult Scler J Exp Transl Clin; 2024; 10(1):20552173241231678. PubMed ID: 38410681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain MRI characteristics in neuromyelitis optica spectrum disorders: A large multi-center retrospective study in China.
    Cao G; Duan Y; Zhang N; Sun J; Li H; Li Y; Li Y; Zeng C; Han X; Zhou F; Huang M; Zhuo Z; Haller S; Liu Y
    Mult Scler Relat Disord; 2020 Nov; 46():102475. PubMed ID: 32898832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deep gray matter atrophy in neuromyelitis optica spectrum disorder and multiple sclerosis.
    Hyun JW; Park G; Kwak K; Jo HJ; Joung A; Kim JH; Lee SH; Kim S; Lee JM; Kim SH; Kim HJ
    Eur J Neurol; 2017 Feb; 24(2):437-445. PubMed ID: 28009104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive impairment in NMOSD-More questions than answers.
    Czarnecka D; Oset M; Karlińska I; Stasiołek M
    Brain Behav; 2020 Nov; 10(11):e01842. PubMed ID: 33022898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of early amnestic mild cognitive impairment without significantly objective memory impairment: a case-controlled study.
    Murayama N; Iseki E; Fujishiro H; Yamamoto R; Ota K; Suzuki M; Nagashima K; Arai H; Sato K
    Psychogeriatrics; 2010 Jun; 10(2):62-8. PubMed ID: 20738809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visual system damage and network maladaptation are associated with cognitive performance in neuromyelitis optica spectrum disorders.
    Chavarro VS; Bellmann-Strobl J; Zimmermann HG; Scheel M; Chien C; Oertel FC; Weygandt M; Ruprecht K; Paul F; Finke C; Brandt AU
    Mult Scler Relat Disord; 2020 Oct; 45():102406. PubMed ID: 32707533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The possible beneficial effects of higher vitamin B6 intake from diet on cognitive function of patients with neuromyelitis optica spectrum disorder.
    Rezaeimanesh N; Saeedi R; Sahraian MA; Razeghi Jahromi S; Naser Moghadasi A
    Mult Scler Relat Disord; 2020 Jul; 42():102132. PubMed ID: 32387974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prevalence of cognitive impairment in patients with neuromyelitis optica spectrum disorders (NMOSD): A systematic review and meta-analysis.
    Moghadasi AN; Mirmosayyeb O; Mohammadi A; Sahraian MA; Ghajarzadeh M
    Mult Scler Relat Disord; 2021 Apr; 49():102757. PubMed ID: 33486400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association between body mass index, demographic and clinical characteristics with cognitive performance in patients with neuromyelitis optica spectrum disorder.
    Rezaeimanesh N; Saeedi R; Sahraian MA; Ghadiri F; Naser Moghadasi A
    Curr J Neurol; 2022 Apr; 21(2):74-82. PubMed ID: 38011484
    [No Abstract]   [Full Text] [Related]  

  • 18. Education-stratified base-rate information on discrepancy scores within and between the Wechsler Adult Intelligence Scale--Third Edition and the Wechsler Memory Scale--Third Edition.
    Dori GA; Chelune GJ
    Psychol Assess; 2004 Jun; 16(2):146-154. PubMed ID: 15222811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repeatable battery for the assessment of neuropsychological status as a screening test in schizophrenia, II: convergent/discriminant validity and diagnostic group comparisons.
    Hobart MP; Goldberg R; Bartko JJ; Gold JM
    Am J Psychiatry; 1999 Dec; 156(12):1951-7. PubMed ID: 10588410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discrepancy analysis between crystallized and fluid intelligence tests: a novel method to detect mild cognitive impairment in patients with asymptomatic carotid artery stenosis.
    Takaiwa A; Kuwayama N; Akioka N; Kashiwazaki D; Kuroda S
    Eur J Neurol; 2018 Feb; 25(2):313-319. PubMed ID: 29078025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.